TESARO, Inc.

Together, We Can Make a Difference

TESARO is an oncology-focused biopharmaceutical company.

learn about TESARO



Our pipeline is sourced through business development and licensing.

learn about our STRATEGY



Our product portfolio currently consists of multiple promising oncology-related product candidates.

learn about our PIPELINE



LATEST NEWS

August 8, 2017
TESARO Announces Second-Quarter 2017 Operating Results

July 27, 2017
TESARO and Takeda Enter Into Exclusive Licensing Agreement to Develop and Commercialize Novel Cancer Therapy Niraparib in Japan

July 25, 2017
TESARO to Announce Second-Quarter 2017 Financial Results on August 8, 2017

June 29, 2017
TESARO Joins OCRFA as Presenting Sponsor of the 2017 Ovarian Cancer National Conference

RESOURCES

We have compiled a number of online resources with current information about cancer research, education, clinical trials and support groups that may be useful to patients and their caregivers.

CULTURE & CAREERS

TESARO is seeking passionate, collaborative professionals to join our team. Our culture supports innovative thinking, the pursuit of excellence, and the sharing of ideas. Refer to our Careers section for a complete list of opportunities.